/AKU
AKU Stock - Akumin Inc.
Healthcare|Medical - Diagnostics & ResearchNASDAQ
$0.29-17.87%
$0.06 (-17.87%) • Oct 25
75
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.40
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+939.1%upside
Target: $3.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AKU
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.29 – $0.29
TARGET (TP)$3.00
STOP LOSS$0.27
RISK/REWARD1:145.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.45
52W High$1.90
52W Low$0.12
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|
| Revenue | $749.63M | $421.08M | $251.28M | $247.44M | $154.78M |
| Gross Profit | $141.25M | $61.34M | $53.48M | $77.56M | $34.35M |
| Gross Margin | 18.8% | 14.6% | 21.3% | 31.3% | 22.2% |
| Operating Income | $41.66M | $13.07M | $20.85M | $45.77M | $15.56M |
| Net Income | $-151,587,000 | $-34,814,000 | $-17,669,000 | $8.65M | $7.57M |
| Net Margin | -20.2% | -8.3% | -7.0% | 3.5% | 4.9% |
| EPS | $-1.69 | $-0.45 | $-0.25 | $0.13 | $0.13 |
Company Overview
Akumin Inc. provides outpatient diagnostic imaging services in the United States. It operates in two segments, Radiology and Oncology. The company offers various medical imaging services, including magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, digital radiography, fluoroscopy, and other diagnostic or interventional radiology procedures through a network of approximately 200 owned and/or operated imaging locations. It provides outpatient radiology, and oncology services and solutions to approximately 1,000 hospitals and health systems across 46 states. Akumin Inc. was founded in 2015 and is headquartered in Plantation, Florida.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$3
Average Target
↑ 939.1% Upside
Now
$3
Low
$3
Average
$3
High
Based on 1 analyst
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 14th 2022 | Canaccord Genuity | Downgrade | Speculative Buy | $3← $3.5 |
Earnings History & Surprises
AKUBeat Rate
0%
Last 7 quarters
Avg Surprise
-46.3%
EPS vs Estimate
Beats / Misses
0/5
2 met exactly
Latest EPS
$-0.38
Q4 2023
EPS Surprise History
Q1 22
No data
Q2 22
No data
Q3 22
No data
Q4 22
No data
Q1 23
No data
Q2 23
No data
Q3 23
No data
Q4 23
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2023 | Nov 8, 2023 | — | $-0.38 | — | — |
Q3 2023 | Aug 9, 2023 | — | $-0.60 | — | — |
Q2 2023 | May 10, 2023 | — | $-0.34 | — | — |
Q1 2023 | Mar 16, 2023 | — | $-0.17 | — | — |
Q4 2022 | Nov 9, 2022 | — | $-0.38 | — | — |
Q3 2022 | Aug 9, 2022 | — | $-0.23 | — | — |
Q2 2022 | May 10, 2022 | — | $-0.32 | — | — |
Q1 2022 | Mar 16, 2022 | — | $-0.26 | — | — |
Q4 2021 | Dec 12, 2021 | — | $-0.02 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.02 | — | — |
Q2 2021 | May 17, 2021 | — | $0.01 | — | — |
Q1 2021 | Mar 31, 2021 | — | $0.03 | — | — |
Q4 2020 | Nov 10, 2020 | — | $-0.03 | — | — |
Q3 2020 | Aug 12, 2020 | $0.15 | $0.04 | -73.3% | ✗ MISS |
Q2 2020 | Jun 3, 2020 | $0.02 | $0.02 | 0.0% | = MET |
Q1 2020 | Mar 31, 2020 | $0.07 | $0.05 | -28.6% | ✗ MISS |
Q4 2019 | Nov 14, 2019 | $0.03 | $0.03 | 0.0% | = MET |
Q3 2019 | Aug 14, 2019 | $0.05 | $-0.01 | -129.7% | ✗ MISS |
Q2 2019 | May 15, 2019 | $0.06 | $0.03 | -50.0% | ✗ MISS |
Q1 2019 | Mar 29, 2019 | $0.07 | $0.04 | -42.9% | ✗ MISS |
Latest News
Loading news...
Frequently Asked Questions about AKU
What is AKU's current stock price?
Akumin Inc. (AKU) is currently trading at $0.29 per share. The stock has moved -17.87% today.
What is the analyst price target for AKU?
The average analyst price target for AKU is $3.00, based on 1 analyst.
What sector is Akumin Inc. in?
Akumin Inc. operates in the Healthcare sector, specifically within the Medical - Diagnostics & Research industry. The company is traded on the NASDAQ exchange.
What is AKU's market cap?
Akumin Inc. has a market capitalization of $0.03 billion, making it a small-cap company.
Does AKU pay dividends?
No, Akumin Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorABDXF
Abingdon Health Plc
$0.07
Mkt Cap: $0.0B
AWH
Aspira Women's Health Inc.
$0.08
Mkt Cap: $0.0B
CNTG
Centogene N.V.
$0.33
Mkt Cap: $0.0B
DMTKQ
DermTech, Inc.
$0.00
Mkt Cap: $0.0B
LMDX
LumiraDx Limited
$0.02
Mkt Cap: $0.0B
ME
23andMe Holding Co.
$0.61
Mkt Cap: $0.0B
MXDHF
MDxHealth S.A.
$0.25
Mkt Cap: $0.0B
NVTA
Invitae Corporation
$0.02
Mkt Cap: $0.0B
PCHM
PharmChem, Inc.
$3.75
Mkt Cap: $0.0B
VRCDF
Verici Dx plc
$0.00
Mkt Cap: $0.0B
Explore stocks similar to AKU for comparison